ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

RTTNews | 1163 days ago
ANI Pharmaceuticals Says FDA Oks ANDA For Clorazepate Dipotassium Tablets

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced Wednesday that it has received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Clorazepate Dipotassium Tablets.

ANI's Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.

The current annual U.S. market for Clorazepate Dipotassium Tablets is approximately $25.8 million, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.

read more
U.S. Dollar Falls Amid Fed Rate Cut Speculation

U.S. Dollar Falls Amid Fed Rate Cut Speculation

The U.S. dollar weakened against other major currencies in the Asian session on Thursday, after the Fed official left the door open for an interest rate cut next month.
RTTNews | 1h 38min ago
Europe Car Sales Rebound In July

Europe Car Sales Rebound In July

Europe's new car sales rebounded in July on strong demand for battery electric and plug-in hybrid cars, the European Automobile Manufacturers' Association reported Thursday. Car registrations in the European Union advanced 7.4 percent year-on-year in July, offsetting June's 7.3 percent decrease. Data showed an annual rise of 39.1 percent for battery-electric and 14.3 percent for hybrid-electric
RTTNews | 2h 42min ago